Can I Take Glycine with Testosterone Enanthate?

What Is the Interaction Between Glycine and Testosterone Enanthate?

The interaction between glycine and Testosterone Enanthate is classified as pharmacodynamic rather than pharmacokinetic. Testosterone Enanthate is a long-acting ester of testosterone that is hydrolyzed after intramuscular injection to release free testosterone, which binds the androgen receptor. Glycine is a non-essential amino acid that acts as an inhibitory neurotransmitter at glycine receptors in the spinal cord and brainstem, modulates N-methyl-D-aspartate (NMDA) receptors as a co-agonist, and serves as a direct precursor to creatine and collagen. These two pathways do not share a common metabolic enzyme, CYP isoform, or transporter, which is why no pharmacokinetic clash has been described.

The clinically relevant overlaps are narrower. Testosterone therapy alters glucose metabolism, hepatic glycogen synthesis, and sleep architecture, while glycine independently influences each of those same domains. That shared territory is where a prescribing clinician should focus attention, not on drug-drug interaction databases, which currently list no interaction between glycine and Testosterone Enanthate.

Pharmacokinetic Profile of Testosterone Enanthate

Testosterone Enanthate injected intramuscularly at 100 to 200 mg produces peak serum testosterone within 24 to 48 hours, followed by a gradual decline over 7 to 10 days. The elimination half-life of the enanthate ester is approximately 4.5 days. Metabolism occurs primarily through 5-alpha-reductase (to dihydrotestosterone) and CYP19A1 aromatase (to estradiol). Glycine does not meaningfully inhibit or induce either enzyme at supplemental doses of 3 to 15 g per day.

Glycine Absorption and Distribution

Oral glycine is absorbed rapidly via the small intestine through sodium-dependent neutral amino acid transporters. Peak plasma concentration occurs within 30 to 60 minutes of ingestion. Glycine does not bind cytochrome P450 enzymes at physiologic concentrations, and it does not alter the volume of distribution of lipophilic androgens. A 2009 study published in the American Journal of Clinical Nutrition confirmed that even 9 g of supplemental glycine produced no hepatic enzyme changes in healthy adults. [1]

How Does Glycine Affect Sleep, and Why Does That Matter on TRT?

Sleep quality is a legitimate consideration for men on Testosterone Enanthate because exogenous testosterone suppresses endogenous LH and FSH through negative feedback, and disrupted sleep further blunts the already-suppressed hypothalamic-pituitary-gonadal axis. Glycine supplementation has documented sleep-promoting effects that could partially offset this concern.

The Bannai 2012 Randomized Crossover Trial

The most-cited human trial on glycine and sleep is a randomized, double-blind, crossover study by Bannai et al. (2012), published in Sleep and Biological Rhythms (N=11 healthy men, 3 g glycine vs. Placebo 30 minutes before sleep). Subjects receiving glycine showed significant reductions in sleep-onset latency and improved subjective sleep quality scores. Polysomnography confirmed reduced time in slow-wave sleep stage 2 and improved transition to restorative stages, though slow-wave sleep total time was not significantly different. [2]

A follow-up translational study from the same group proposed that glycine lowers core body temperature by dilating peripheral blood vessels, which is the same physiologic mechanism that triggers natural sleep onset. [3] That mechanism is independent of testosterone levels, meaning it should function identically in eugonadal and hypogonadal men.

Sleep Architecture and Testosterone Secretion

In healthy men, roughly 70% of daily testosterone secretion is coupled to slow-wave sleep. Exogenous Testosterone Enanthate replaces endogenous production, so the sleep-secretion link is severed. Nevertheless, restorative sleep still matters for insulin sensitivity, cortisol regulation, and myofibrillar protein synthesis. Improving sleep quality with 3 g nightly glycine may support those downstream outcomes even when testosterone is administered exogenously.

Does Glycine Affect Blood Sugar While on Testosterone Enanthate?

Both glycine and testosterone independently modulate glucose metabolism, so this is the area requiring the most clinical attention.

Glycine's Glycemic Mechanism

Glycine stimulates glucagon-like peptide-1 (GLP-1) secretion from intestinal L-cells. A randomized trial by Gannon and Nuttall (2004) in Diabetes Care (N=16 subjects with type 2 diabetes) showed that 5 g of glycine ingested with a glucose load reduced the postprandial glucose area under the curve by approximately 25% compared with placebo (P<0.01). [4] The effect is dose-dependent and attenuates above 5 to 7 g in single doses.

Testosterone's Glycemic Effects

Testosterone Enanthate therapy improves insulin sensitivity in hypogonadal men. A 2015 meta-analysis in the European Journal of Endocrinology (12 RCTs, N=742 men) found that testosterone therapy reduced fasting glucose by a mean of 0.98 mmol/L and HOMA-IR by 1.73 points compared with placebo. [5] The mechanism involves androgen-receptor-mediated upregulation of GLUT4 translocation in skeletal muscle.

Combined Glycemic Effect

When both are present, glycine's GLP-1-mediated effect and testosterone's GLUT4-mediated effect operate through different pathways and may produce additive glucose lowering. For most euglycemic men on standard TRT doses (100 to 200 mg Testosterone Enanthate every 7 to 14 days), this is not a safety concern. For men with pre-existing insulin resistance, type 2 diabetes, or concurrent use of insulin secretagogues, fasting glucose should be checked at baseline and at 8 to 12 weeks after starting glycine. Hypoglycemia from glycine alone at 3 to 5 g is not documented in the literature, but the additive context warrants awareness.

Collagen Synthesis: A Genuine Combination Between Glycine and Testosterone

One of the most practically useful reasons a man on Testosterone Enanthate might choose glycine is connective tissue support. Testosterone and glycine each contribute to collagen synthesis, but through separate steps in the same pathway.

Why Glycine Is Rate-Limiting for Collagen

Collagen is approximately 33% glycine by amino acid composition. A 2018 paper in Nutrients by Shaw et al. Confirmed that dietary glycine intake from whole foods is typically 1.5 to 3 g per day, while the estimated requirement for collagen synthesis is closer to 10 g per day. [6] That gap of roughly 7 g is not met by endogenous biosynthesis alone. Supplemental glycine at 5 to 10 g taken 30 to 60 minutes before training with co-ingested vitamin C (which is required for hydroxylation of proline residues) measurably increases collagen synthesis markers.

Testosterone's Role in Collagen Remodeling

Testosterone increases IGF-1 signaling in fibroblasts, which upregulates type I and type III collagen gene expression. A study in the Journal of Clinical Endocrinology and Metabolism (2012, N=30 men) found that 24 weeks of testosterone therapy increased serum PINP (N-terminal propeptide of type I procollagen) by 38% versus baseline (P<0.001). [7] Elevated PINP indicates active collagen deposition.

When glycine availability is adequate, the substrate for that increased collagen-gene expression is not limiting. When glycine is deficient, the anabolic signal from testosterone may not fully translate into new collagen strands. This is not a drug interaction in the pharmacologic sense, but it is a physiologically relevant complementary relationship.

Practical Collagen Stack Protocol

For men on Testosterone Enanthate who want to support connective tissue, the evidence points toward:

• 5 to 10 g glycine (or 15 to 20 g hydrolyzed collagen peptides providing equivalent glycine) 30 to 60 minutes before resistance training
• 50 mg vitamin C co-ingested with glycine to support prolyl hydroxylase activity
• Injection timing of Testosterone Enanthate consistent with physician guidance (typically 100 to 200 mg IM every 7 to 14 days)

No dose separation from the testosterone injection is necessary because glycine and Testosterone Enanthate are not competing for the same metabolic route.

Is Glycine Safe with Testosterone Enanthate? Known Risks and Monitoring

Adverse Effect Profile of Glycine

Glycine is considered Generally Recognized as Safe (GRAS) by the FDA at doses up to 30 g per day in food applications. [8] At supplemental doses of 3 to 15 g per day, the most common reported side effect is mild GI discomfort (loose stools, nausea) at the higher end of that range. No hepatotoxicity, nephrotoxicity, or hematologic adverse effects have been attributed to glycine in published clinical trials.

The Natural Medicines Comprehensive Database rates the evidence for glycine's safety as "likely safe" for short-term use and "possibly safe" for longer-term use, with the caveat that long-term data beyond 12 months in clinical populations are limited.

Adverse Effect Profile of Testosterone Enanthate

Testosterone Enanthate carries well-documented risks including erythrocytosis (hematocrit rise), acne, exacerbation of benign prostatic hyperplasia, hepatic stress at high or oral doses (less relevant for IM enanthate), and suppression of spermatogenesis. The FDA-approved prescribing information for Delatestryl notes that polycythemia is one of the most common adverse effects requiring monitoring. [9]

Glycine does not affect erythropoiesis, PSA, or hepatic function at supplemental doses and therefore does not compound any of these specific testosterone-related risks.

Recommended Monitoring Protocol

For a man initiating glycine supplementation while already stable on Testosterone Enanthate:

• Baseline labs before adding glycine: fasting glucose, HbA1c, comprehensive metabolic panel, testosterone trough (drawn just before the next injection), hematocrit, PSA
• Follow-up at 8 to 12 weeks: fasting glucose and HbA1c (to detect additive glucose-lowering if pre-diabetes is present), symptom check for sleep quality and GI tolerability
• Ongoing every 6 months: same testosterone monitoring panel per standard TRT guidelines (Endocrine Society Clinical Practice Guideline, 2018) [10]

The Endocrine Society's 2018 Testosterone Therapy in Men with Hypogonadism guideline states: "We suggest monitoring hematocrit at baseline, at 3 to 6 months, and then annually." [10] Adding glycine does not change that monitoring interval.

Dose and Timing Recommendations for Glycine on Testosterone Enanthate

The optimal dose depends on the primary goal.

Sleep Optimization

The Bannai 2012 trial used 3 g orally 30 to 60 minutes before sleep. [2] This is the lowest effective dose with the most consistent evidence. No dose escalation above 3 g improved sleep outcomes in that study, so higher doses are not justified for the sleep indication alone.

Collagen Synthesis Support

Shaw et al. (2017, American Journal of Clinical Nutrition, N=8, randomized crossover) found that 5 g of gelatin (providing approximately 2.5 g glycine) taken 1 hour before exercise doubled collagen synthesis markers compared with placebo. [11] Pure glycine at 5 g would provide an equivalent or slightly higher substrate dose. For connective-tissue goals, 5 g before training is a reasonable starting point.

General Amino Acid Supplementation

Doses up to 10 g per day split across two servings appear safe based on the available short-term data. Doses above 15 g per day have not been studied in the context of TRT specifically, and there is no established rationale for exceeding 10 g per day on standard Testosterone Enanthate protocols.

Timing Relative to Testosterone Injection

No evidence supports a required separation window between oral glycine and intramuscular Testosterone Enanthate. The injection depot and the oral supplement are absorbed through entirely different routes and processed by different tissues. Patients may take glycine at any time that suits their routine, with the caveat that pre-sleep dosing (3 g) and pre-workout dosing (5 g) each have dedicated supporting evidence for their respective outcomes.

Who Should Exercise Extra Caution?

Most men on standard TRT doses will not encounter problems combining glycine supplementation. A smaller subset warrants closer attention.

Men with Type 2 Diabetes or Pre-Diabetes

The additive glucose-lowering of glycine plus testosterone could reduce the required dose of metformin or a sulfonylurea. This is not categorically dangerous, but it should prompt a medication review with the prescribing physician before starting glycine at doses above 5 g per day.

Men on Anticoagulants

Testosterone Enanthate therapy has a small but documented interaction with warfarin, increasing INR in some patients. Glycine does not directly affect coagulation factors, but any supplement change in a patient on warfarin should be reported to the managing clinician so INR can be checked within 2 to 4 weeks of the change.

Men with Schizophrenia or Schizoaffective Disorder

High-dose glycine (30 to 60 g per day) has been studied as an adjunctive treatment for negative symptoms of schizophrenia through NMDA co-agonism. At those high doses, glycine may interact with antipsychotic medications. At the 3 to 10 g range used in wellness contexts, this is not a clinical concern, but it is worth flagging for completeness.

Men Under Age 25

Testosterone Enanthate in men with open epiphyses carries risk of premature growth plate closure. This is a testosterone-specific concern. Glycine does not accelerate or worsen epiphyseal maturation, but prescribing exogenous testosterone to men under 25 requires careful endocrinologic evaluation regardless of co-supplements.

What the Literature Gaps Mean for Clinical Decision-Making

No randomized controlled trial has specifically studied glycine co-supplementation in men receiving Testosterone Enanthate therapy. That absence of data is not the same as evidence of harm. The mechanistic and safety profiles of each substance are well-characterized independently, and the pathways do not intersect in ways that predict pharmacokinetic interference.

The glycemic overlap is real but modest at typical supplemental doses. The sleep benefit is supported by the Bannai crossover data. The collagen synthesis rationale is mechanistically grounded. What is missing is a head-to-head cohort study measuring connective-tissue outcomes, body composition, or sleep polysomnography in TRT patients specifically randomized to glycine versus placebo. That study does not yet exist as of this writing.

For now, clinical judgment based on individual risk factors and goals should guide the decision. A prescribing physician reviewing this article should note that current evidence supports glycine as a low-risk addition to Testosterone Enanthate therapy when used at 3 to 10 g per day, with standard TRT monitoring unchanged.